Search results for "Chronic Kidney Disease"
An atypical presentation of microscopic polyangiitis
A patient was admitted after outpatient labs indicated acute worsening of kidney disease and anemia.
https://acphospitalist.acponline.org/archives/2022/10/26/free/brief-case-an-atypical-presentation-of-microscopic-polyangiitis.htm
26 Oct 2022
Early invasive treatment for NSTEMI may not benefit patients with chronic kidney disease
Early treatment for non-ST-segment elevation myocardial infarction (NSTEMI) was associated with a 30% improvement in survival compared to delayed treatment, but the association was attenuated as renal function declined, a retrospective study in Israel found.
https://acphospitalist.acponline.org/archives/2022/10/05/early-invasive-treatment-for-nstemi-may-not-benefit-patients-with-chronic-kidney-disease.htm
5 Oct 2022
Gabapentin associated with delirium, pneumonia in older postop patients
A propensity-matched study found that patients ages 65 years and older who received gabapentin after surgery had a 3.4% risk of delirium and 1.3% risk of pneumonia, compared to 2.6% and 1.2%, respectively, in patients not taking the drug. Risk of in-hospital death was similar between groups.
https://acphospitalist.acponline.org/archives/2022/09/28/gabapentin-associated-with-delirium-pneumonia-in-older-postop-patients.htm
28 Sep 2022
Meth use associated with higher risk of heart failure, myocardial infarction, stroke
An analysis of hospitalized patients found that those who used methamphetamine had a 32% increase in cardiovascular disease risk compared to nonusers who also had been hospitalized. Risk increases associated with misuse of alcohol and cocaine were 28% and 47%, respectively.
https://acphospitalist.acponline.org/archives/2022/08/10/meth-use-associated-with-higher-risk-of-heart-failure-myocardial-infarction-stroke.htm
10 Aug 2022
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://acphospitalist.acponline.org/weekly/archives/2021/12/15/4.htm
15 Dec 2021
NKF-ASN task force issues final report on use of race in diagnosing kidney disease
Effective immediately in the U.S., estimated glomerular filtration rate should be calculated with an updated equation that does not include a race modifier for Black patients, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) said.
https://acphospitalist.acponline.org/weekly/archives/2021/09/29/4.htm
29 Sep 2021
Pacemakers, stents recalled
Recalls, warnings, alerts, and approvals.
https://acphospitalist.acponline.org/archives/2021/07/fda-update.htm
15 Jul 2021
Ask Dr. Pinson
Get answers to questions about obesity, ultrasound guidance, and other coding conundrums.
https://acphospitalist.acponline.org/archives/2021/07/coding-corner-qa.htm
15 Jul 2021
Diuretic guidance, endocarditis risks, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/recent-research.htm
15 Jun 2021
Residents reimagine anti-racism curriculum
A new Race, Bias, and Advocacy in Medicine pathway gave trainees an opening to focus on these issues.
https://acphospitalist.acponline.org/archives/2021/05/residents-reimagine-anti-racism-curriculum.htm
15 May 2021